Hair Loss for Women: What Is Actually Driving It, and What Actually Helps

Most women who come to me about hair loss have already been told its just stress, or just aging, or just genetics. Some have been quietly losing hair for a year and only mention it after I ask. Others bring it up before they sit down, holding a Ziploc bag of what came out of the shower drain last week. Hair loss in women is rarely one thing. Its also rarely "just stress." Lets walk through what the workup actually looks like, what treatments have real evidence behind them, and what timeline to expect.

The differential is wider than people assume

When a woman tells me her hair is thinning or shedding, the first question is not "what should we treat" but "what are we actually looking at?" The five most common patterns:

1. Telogen effluvium (diffuse shedding, usually temporary)

A large fraction of hairs shift from the growth phase to the shedding phase at roughly the same time, then shed together 2 to 3 months after the trigger. The trigger can be:

• Significant illness, including COVID
• Surgery or general anesthesia
• Major weight loss (intentional or from a GLP-1 medication)
• Postpartum (very common; usually 3 to 6 months after delivery)
• Sudden major stress (loss, divorce, job change)
• Iron deficiency or vitamin D deficiency
• Starting or stopping certain medications (oral contraceptives, antidepressants)

Telogen effluvium usually resolves on its own as the underlying trigger resolves, with regrowth visible at 6 to 12 months. The key is identifying the trigger and addressing it.

2. Female pattern hair loss (FPHL)

This is the female version of androgenetic alopecia. The pattern looks different from mens: usually a widening center part, diffuse thinning across the top and crown, with the hairline often preserved. It is genetically driven and influenced by androgens (testosterone and DHT), but the relationship is more complex than in men. Many women with classic FPHL have totally normal androgen levels.

3. Postpartum shedding

A specific subtype of telogen effluvium. During pregnancy, high estrogen keeps more hair in the growth phase than usual; postpartum, those hairs all shift to shedding together around month 3 to 6. The shedding is dramatic but expected. Most women see substantial regrowth by 9 to 12 months postpartum.

4. Thyroid-driven shedding

Both hypothyroidism and hyperthyroidism can drive hair loss, and the change can precede the clinical diagnosis by months. Hashimoto's, postpartum thyroiditis, and Graves' all show up this way at times.

5. Scarring alopecias and alopecia areata

These are different categories. Scarring alopecias (frontal fibrosing alopecia, lichen planopilaris, central centrifugal cicatricial alopecia) can permanently destroy follicles and need dermatology referral and biopsy. Alopecia areata produces well-defined patches of total loss and has its own treatment pathway. We screen for both during the initial workup.

The labs we actually run

Most women I see for hair loss have had "labs" before. Almost never the right ones. Heres the panel we use:

• Ferritin (iron storage). Below 50 ng/mL is suboptimal for hair growth in most studies; below 30 is frankly low. Standard "anemia" workups using hemoglobin alone routinely miss it.
• TSH, free T4, free T3, TPO antibodies. Full thyroid panel rather than just TSH. We are looking for early Hashimoto's, subclinical thyroid disease, and postpartum thyroiditis.
• 25-OH vitamin D. Deficiency is widespread in Philadelphia winters and associated with worse hair density.
• CBC and CMP. Baseline, plus the CBC catches the rare anemia thats driving things.
• Sex hormones. Total and free testosterone, DHEA-S, SHBG, estradiol, progesterone (in the right phase of the cycle for premenopausal women). If the picture fits PCOS, we add fasting insulin and HbA1c. If perimenopause is the driver, we add FSH and LH.
• HbA1c and fasting insulin if metabolic disease is in the picture.
• Vitamin B12, zinc, biotin only if the dietary or absorption story suggests deficiency. We do not order these reflexively.
• ANA or other autoimmune labs if the pattern looks scarring or autoimmune.

This is more lab work than most women have had run on their hair before. Its also the lab work that actually finds the driver.

Evidence-based treatments

Once we know whats actually driving the loss, the treatment options narrow.

Minoxidil

FDA-approved for female pattern hair loss as a topical (2% or 5% solution or foam, once or twice daily). It works by prolonging the growth phase, improving follicular blood flow, and helping miniaturized follicles produce thicker shafts. Low-dose oral minoxidil (typically 1 to 2.5 mg daily for women) is increasingly used off-label in dermatology and primary care, especially for women who dont tolerate the topical (scalp irritation, dryness, the visible residue at the part line). The side effect profile (mild lower-extremity edema, possible mild facial hair growth, occasional cardiovascular effects requiring monitoring) is real but manageable in most patients. We discuss the trade-offs honestly.

Spironolactone

An oral medication originally used for blood pressure that blocks androgen activity at the receptor and reduces testosterone synthesis modestly. Typical dose for female pattern hair loss is 50 to 200 mg daily. It is not FDA-approved for hair loss but has decades of off-label use and a reasonable evidence base. Spironolactone is particularly useful for women with PCOS-driven hair loss, or for FPHL not responding to minoxidil alone. It is a teratogen, so reliable contraception is required during use; we discuss this clearly before starting.

Hormone therapy in perimenopause and menopause

When hair thinning starts in the 40s or 50s and correlates with other perimenopausal symptoms (hot flashes, sleep disruption, cycle changes), addressing the underlying hormonal shift often improves the hair as well. We treat the hormone story directly when its appropriate, not as a side note to a hair-only conversation.

Treating the trigger in telogen effluvium

When the workup reveals a specific driver (low ferritin, hypothyroid, vitamin D deficiency, major stress, postpartum), the treatment is to fix the driver. The hair follows on a 3 to 9 month timeline.

Topical finasteride and dutasteride

Compounded topical finasteride or dutasteride is sometimes used off-label for FPHL in postmenopausal women or women using reliable contraception. The evidence is smaller than for spironolactone, and we discuss the trade-off honestly.

What we do not prescribe

A few things you may see online that we do not offer:

• Compounded peptides marketed for hair (GHK-Cu injectables, "hair peptides"). State medical boards prohibit physician prescribing of non-FDA-approved peptides.
• Generic hair-vitamin gummies with proprietary blends, biotin megadoses, and dozens of ingredients. Biotin at high doses can falsely alter several lab tests (TSH, troponin) and is rarely the actual deficiency.
• Expensive in-office treatments without evidence parity. PRP has modest, mixed evidence and we discuss it as an adjunct when patients ask.

The lifestyle and nutrition layer

Hair is structural protein, and the follicle is one of the most metabolically demanding tissues in the body. Stress it through any of the levers below and the hair tells the story months later.

• Protein. Chronically eating below 1.2 g/kg/day in active adults can drag on hair density. Vegetarian and vegan diets need extra attention to total protein and specific amino acids (lysine, methionine).
• Iron. Heavy menstrual bleeding, pregnancy, GI absorption issues, vegetarian diets, and certain medications (PPIs) all set up iron deficiency that can drive shedding even when the CBC looks "normal."
• Sleep. Chronic short sleep raises cortisol and worsens telogen effluvium. The relationship is direct.
• Crash dieting and rapid weight loss. Including from GLP-1 medications. We watch for it at the 3-month mark and adjust nutrition and titration.
• Major stress. We dont moralize. We acknowledge the load, address what can be addressed, and time expectations honestly.

Guidance from the clinic

"Most women I see have been told their hair loss is just aging or just stress. Its almost never just one thing. The right answer usually shows up when we actually look at the labs they should have had run two years ago."

Actionable Steps in Philly

Book Your Warm Invitation Call

Scientific References

1. Sinclair R. "Female Pattern Hair Loss: A Pilot Study Investigating Combination Therapy with Low-Dose Oral Minoxidil and Spironolactone." Int J Dermatol. 2018.
2. Trost LB, et al. "The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss." J Am Acad Dermatol. 2006.
3. Ramos PM, Miot HA. "Female Pattern Hair Loss: A Clinical and Pathophysiological Review." An Bras Dermatol. 2015.
4. Vincent M, Yogiraj K. "A Descriptive Study of Alopecia Patterns and Their Relation to Thyroid Dysfunction." Int J Trichology. 2013.
5. Mirmirani P. "Hormonal Changes in Menopause: Do They Contribute to a 'Midlife Hair Crisis' in Women?" Br J Dermatol. 2011.

---

Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all"; the right treatment plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.